文献速递脑血管病

急性缺血性卒中患者的1型心肌梗死

Type 1 Myocardial Infarction in Patients With Acute Ischemic Stroke.
PubMed 文献 · JAMA Neurol · 2024-01-01

这项跨26个德国中心的前瞻性观察性横断面研究纳入254例急性缺血性卒中伴高敏肌钙蛋白升高患者,247例判定了终点,其中126例(51%)存在心肌梗死,50例(20%)为1型心肌梗死。高敏肌钙蛋白动态变化与心肌梗死无关,而基线绝对高敏肌钙蛋白值与1型心肌梗死独立相关,最佳切点为正常上限的5至10倍。

要点

  • 急性缺血性卒中伴高敏肌钙蛋白升高患者中,1型心肌梗死占20%(50/247)。
  • 高敏肌钙蛋白动态变化与心肌梗死无关(未校正32% vs 38%,χ2 P=0.30;校正后OR 1.05,95%CI 0.31-3.33)。
  • 基线绝对高敏肌钙蛋白值独立关联1型心肌梗死,最佳切点为正常上限5至10倍。

核心结论

  • 在急性缺血性卒中患者中,高敏肌钙蛋白动态变化不能识别心肌梗死,提示动态变化不反映潜在病理生理机制。
  • 探索性分析中,极高的绝对高敏肌钙蛋白值与1型心肌梗死诊断相关。
  • 需要进一步研究如何最佳识别应接受冠状动脉造影的卒中患者。

研究设计与样本

  • 前瞻性观察性横断面研究,采用盲法终点评估,在德国26个中心开展。
  • 纳入72小时内急性缺血性卒中且满足以下任一条件者:入院高敏肌钙蛋白>52 ng/L,或高敏肌钙蛋白高于正常上限且重复测量变化>20%。
  • 2018年8月至2020年10月入组,随访1年;统计分析于2022年4月至2023年8月进行。
  • 共纳入254例患者,247例判定终点:中位年龄75岁(IQR 66-82),女性117例(47%),男性130例(53%)。

主要发现

  • 247例中126例(51%)存在心肌梗死,其中50例(20%)分类为1型心肌梗死。
  • 高敏肌钙蛋白动态变化与心肌梗死无关:未校正比较32% vs 38%(χ2 P=0.30),校正后OR 1.05(95%CI 0.31-3.33)。
  • 基线绝对高敏肌钙蛋白值独立关联1型心肌梗死,预测1型心肌梗死的最佳切点为高敏肌钙蛋白值正常上限的5至10倍。

关键数值与推荐

  • 心肌梗死诊断由独立终点委员会基于心电图、超声心动图和冠状动脉造影结果判定。
  • 高敏肌钙蛋白动态变化定义为>50%变化,为原研究主要假设的判定指标。

局限性

  • 需要进一步研究如何最佳识别应接受冠状动脉造影的卒中患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Elevated values of high-sensitivity cardiac troponin (hs-cTn) are common in patients with acute ischemic stroke and are associated with poor prognosis. However, diagnostic and therapeutic implications in patients with ischemic stroke remain unclear. OBJECTIVE: To identify factors indicative of myocardial infarction (MI) in patients with acute ischemic stroke and hs-cTn elevation. The primary hypothesis was that a dynamic change of hs-cTn values (>50% change) in patients with acute ischemic stroke indicates MI. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study was a prospective, observational study with blinded end-point assessment conducted across 26 sites in Germany. Patients were included if they had acute ischemic stroke within 72 hours and either (1) highly elevated hs-cTn values on admission (>52 ng/L) or (2) hs-cTn levels above the upper limit of normal and a greater than 20% change at repeated measurements. Patients were enrolled between August 2018 and October 2020 and had 1 year of follow-up. Statistical analysis was performed between April 2022 and August 2023. EXPOSURE: Standardized electrocardiography, echocardiography, and coronary angiography. MAIN OUTCOME AND MEASURES: Diagnosis of MI as adjudicated by an independent end-point committee based on the findings of electrocardiography, echocardiography, and coronary angiography. RESULTS: In total, 254 patients were included. End points were adjudicated in 247 patients (median [IQR] age, 75 [66-82] years; 117 were female [47%] and 130 male [53%]). MI was present in 126 of 247 patients (51%) and classified as type 1 MI in 50 patients (20%). Dynamic change in hs-cTn value was not associated with MI in univariable (32% vs 38%; χ2 P = .30) or adjusted comparison (odds ratio, 1.05; 95% CI, 0.31-3.33). The baseline absolute hs-cTn value was independently associated with type 1 MI. The best cutoffs for predicting type 1 MI were at hs-cTn values 5 to 10 times the upper limit normal. CONCLUSIONS AND RELEVANCE: This study found that in patients with acute ischemic stroke, a dynamic change in hs-cTn values did not identify MI, underscoring that dynamic changes do not identify the underlying pathophysiological mechanism. In exploratory analyses, very high absolute hs-cTn values were associated with a diagnosis of type 1 MI. Further studies are needed how to best identify patients with stroke who should undergo coronary angiography.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Nolte CH, von Rennenberg R, Litmeier S, et al. Type 1 Myocardial Infarction in Patients With Acute Ischemic Stroke. JAMA Neurol. 2024. PMID: 38829625. doi:10.1001/jamaneurol.2024.1552

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。